Christian Rainer Wirtz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Christian Rainer Wirtz has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Andrej Pala
Department of Neurosurgery, Ulm University, Lindenallee 2, 89312 Günzburg, Germany
3 shared publications - Nadja Grübel
Peripheral Nerve Unit, Department of Neurosurgery, University of Ulm, Lindenallee 2, 89312 Günzburg, Germany
3 shared publications - Lennart W. Sannwald
Department of Neurosurgery, Ulm University, Ulm, Germany
2 shared publications - Maria Teresa Pedro
Peripheral Nerve Unit, Department of Neurosurgery, University of Ulm, Lindenallee 2, 89312 Günzburg, Germany
2 shared publications - Nora Franziska Dengler
Department of Neurosurgery, Helios Hospital Bad Saarow, Pieskower Str. 33, 15526 Bad Saarow, Germany
2 shared publications - Ralph König
Department of Neurosurgery, University of Ulm, District Hospital Günzburg, Lindenallee 2, 89312 Günzburg, Germany
2 shared publications
Latest Publications
- Open Access
Contemporary Profile of Hybrid Nerve Sheath Tumors: Clinical, Anatomical, and Imaging Characteristics
Objective: Hybrid peripheral nerve sheath tumors (HPNSTs) are rare benign neoplasms combining features of more than one peripheral nerve sheath tumor subtype—most commonly schwannoma, neurofibroma, and/or perineurioma. Multicenter registry data were used to improve their clinical, radiological, histopathological, and syndromic characterization. Methods: This study analyzed 55 histologically confirmed HPNSTs in 52 patients from a multicenter registry of 627 surgically treated patients at four tertiary neurosurgical centers in Germany and Austria. Demographic, anatomical, clinical, imaging, histopathological, surgical, follow-up, and syndrome-associated variables were evaluated. Results: HPNSTs were identified in 52/627 surgically treated registry patients (8.3%), comprising 55 lesions. Median age at surgery was 57 years (IQR 44–63 years; range, 18–78), and 27/52 patients (51.9%) were female. Lower-extremity or lumbosacral lesions were more common than upper-extremity or cervicothoracic lesions (32 vs. 23 cases). Schwannoma/neurofibroma hybrid was the predominant subtype (51/55, 92.7%), followed by schwannoma/perineurioma and triphasic schwannoma/neurofibroma/perineurioma tumors (2/55 each, 3.6%). All tumors were benign. Provoked pain was the leading symptom (47/55, 85.5%), whereas motor deficits were uncommon (5/55, 9.1%). MRI frequently showed inhomogeneous contrast enhancement (42/48, 87.5%) and cystic components (19/47, 40.4%). Complete resection was achieved in 49/55 tumors (89.1%). A documented or suspected syndromic association was present in 18/52 patients (34.6%). Conclusions: In this surgically selected multicenter registry cohort, HPNSTs accounted for 8.3% of operated peripheral nerve tumor patients. This cohort frequency should not be interpreted as population prevalence. The integrated clinical, imaging, pathological, and surgical data highlight pain burden, multifocality, and potential syndromic associations. Long-term behavior cannot be determined because follow-up was short and incomplete.
Open AccessContemporary Profile of Hybrid Nerve Sheath Tumors: Clinical, Anatomical, and Imaging Characteristics
Objective: Hybrid peripheral nerve sheath tumors (HPNSTs) are rare benign neoplasms combining features of more than one peripheral nerve sheath tumor subtype—most commonly schwannoma, neurofibroma, and/or perineurioma. Multicenter registry data were used to improve their clinical, radiological, histopathological, and syndromic characterization. Methods: This study analyzed 55 histologically confirmed HPNSTs in 52 patients from a multicenter registry of 627 surgically treated patients at four tertiary neurosurgical centers in Germany and Austria. Demographic, anatomical, clinical, imaging, histopathological, surgical, follow-up, and syndrome-associated variables were evaluated. Results: HPNSTs were identified in 52/627 surgically treated registry patients (8.3%), comprising 55 lesions. Median age at surgery was 57 years (IQR 44–63 years; range, 18–78), and 27/52 patients (51.9%) were female. Lower-extremity or lumbosacral lesions were more common than upper-extremity or cervicothoracic lesions (32 vs. 23 cases). Schwannoma/neurofibroma hybrid was the predominant subtype (51/55, 92.7%), followed by schwannoma/perineurioma and triphasic schwannoma/neurofibroma/perineurioma tumors (2/55 each, 3.6%). All tumors were benign. Provoked pain was the leading symptom (47/55, 85.5%), whereas motor deficits were uncommon (5/55, 9.1%). MRI frequently showed inhomogeneous contrast enhancement (42/48, 87.5%) and cystic components (19/47, 40.4%). Complete resection was achieved in 49/55 tumors (89.1%). A documented or suspected syndromic association was present in 18/52 patients (34.6%). Conclusions: In this surgically selected multicenter registry cohort, HPNSTs accounted for 8.3% of operated peripheral nerve tumor patients. This cohort frequency should not be interpreted as population prevalence. The integrated clinical, imaging, pathological, and surgical data highlight pain burden, multifocality, and potential syndromic associations. Long-term behavior cannot be determined because follow-up was short and incomplete.
- 9 July 2026
- Published by Wolters Kluwer Health in Neurosurgery
Epistemology of Kocher's Point
Although ventricular puncture remains one of the oldest and most frequent procedures in neurosurgery and most neurosurgeons perform ventriculostomy via Kocher's point, Swiss surgeon Theodor Emil Kocher is almost never cited. In fact, a plethora of measurements is ascribed to “Kocher's point.” This article tracks the original technique described by Theodor E. Kocher. His thorough investigation of craniocerebral topography enabled him to devise a cranioencephalometer with which he was able to localize cerebral areas on the surface of the cranium in living patients for surgical planning. The measurements of Kocher's point depend on individual craniometry. Kocher originally described ventricular puncture via a trephination 2.5 to 3.0-cm paramedian to a point between the anterior and middle third on the nasion-inion-line. This reliably helps to stay on or before the coronal suture when puncturing the frontal horn of the lateral ventricle—the most common neurosurgical procedure—and represents a safe entry point with minimal risk of injury to eloquent primary, secondary, or supplementary motor cortex as well as bridging veins or venous lacunae.
- 9 July 2026
- Published by Wolters Kluwer Health in Neurosurgery
Epistemology of Kocher's Point
Although ventricular puncture remains one of the oldest and most frequent procedures in neurosurgery and most neurosurgeons perform ventriculostomy via Kocher's point, Swiss surgeon Theodor Emil Kocher is almost never cited. In fact, a plethora of measurements is ascribed to “Kocher's point.” This article tracks the original technique described by Theodor E. Kocher. His thorough investigation of craniocerebral topography enabled him to devise a cranioencephalometer with which he was able to localize cerebral areas on the surface of the cranium in living patients for surgical planning. The measurements of Kocher's point depend on individual craniometry. Kocher originally described ventricular puncture via a trephination 2.5 to 3.0-cm paramedian to a point between the anterior and middle third on the nasion-inion-line. This reliably helps to stay on or before the coronal suture when puncturing the frontal horn of the lateral ventricle—the most common neurosurgical procedure—and represents a safe entry point with minimal risk of injury to eloquent primary, secondary, or supplementary motor cortex as well as bridging veins or venous lacunae.
- Open Access
- 8 January 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (1) , 36
Pituitary Neuroendocrine Tumors Extending Primarily Below the Sella and into the Clivus: A Distinct Growth Pattern with Specific Challenges
Evaluation of pituitary neuroendocrine tumors remains complex depending on the exact growth pattern, involvement of critical neurovascular structures, pituitary function and endocrinological activity of the tumor. A predominant growth into the sphenoid sinus and clivus poses specific challenges. We reviewed 557 surgeries for pituitary neuroendocrine tumors in an endonasal endoscopic technique performed between 1 January 2015 and 31 August 2025 to identify 13 cases (2.3%). Clinical, radiological and surgical data were selected by chart review. Thirteen cases aged from 31 to 68 years with almost exclusively non-functioning or clinically silent tumors (92%) were identified. Clival infiltration was restricted to the dorsum sellae in 2/13 (15%), spread to the floor of the sphenoid in 6/13 (46%) and extended inferior to the sphenoid in 5/13 (38%) cases with a high rate of cavernous sinus (62%) and sphenoid sinus infiltration (69%). Complete resection was achieved in 31%, and the residual tumor was clival/sphenoidal in 5/13 cases or within the cavernous sinus in 6/13 cases. The diaphragma sellae was reported to be intact in 92% of cases, and postoperative transient arginine vasopressin deficiency did not occur. Pituitary neuroendocrine tumors predominantly growing below the sella and infiltrating the clivus and sphenoid present specific challenges with a high rate of preoperative pituitary insufficiency, frequent cavernous sinus infiltration and postoperative tumor residuals in the cavernous sinus, sphenoid bone and clivus which are sometimes difficult to delineate. The surgical approach must be tailored specifically to treat the clival infiltration zone to reduce the risk of recurrence.
- 8 January 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (1) , 36
Open AccessPituitary Neuroendocrine Tumors Extending Primarily Below the Sella and into the Clivus: A Distinct Growth Pattern with Specific Challenges
Evaluation of pituitary neuroendocrine tumors remains complex depending on the exact growth pattern, involvement of critical neurovascular structures, pituitary function and endocrinological activity of the tumor. A predominant growth into the sphenoid sinus and clivus poses specific challenges. We reviewed 557 surgeries for pituitary neuroendocrine tumors in an endonasal endoscopic technique performed between 1 January 2015 and 31 August 2025 to identify 13 cases (2.3%). Clinical, radiological and surgical data were selected by chart review. Thirteen cases aged from 31 to 68 years with almost exclusively non-functioning or clinically silent tumors (92%) were identified. Clival infiltration was restricted to the dorsum sellae in 2/13 (15%), spread to the floor of the sphenoid in 6/13 (46%) and extended inferior to the sphenoid in 5/13 (38%) cases with a high rate of cavernous sinus (62%) and sphenoid sinus infiltration (69%). Complete resection was achieved in 31%, and the residual tumor was clival/sphenoidal in 5/13 cases or within the cavernous sinus in 6/13 cases. The diaphragma sellae was reported to be intact in 92% of cases, and postoperative transient arginine vasopressin deficiency did not occur. Pituitary neuroendocrine tumors predominantly growing below the sella and infiltrating the clivus and sphenoid present specific challenges with a high rate of preoperative pituitary insufficiency, frequent cavernous sinus infiltration and postoperative tumor residuals in the cavernous sinus, sphenoid bone and clivus which are sometimes difficult to delineate. The surgical approach must be tailored specifically to treat the clival infiltration zone to reduce the risk of recurrence.
- Open Access
Navigating Rarity: Pathological Challenges and Diagnostic Ambiguity in Rare Gliomas—A Case Series with a Focus on Personalized Treatment and Quality of Life
Gliomas are incurable, heterogeneous brain tumors, with rare forms often constituting diagnostic and treatment challenges. Molecular diagnostics, mainly implemented through the World Health Organization (WHO) 2021 guidelines, have refined the classification, but highlight difficulties in diagnosing rare gliomas remain. This case series analyzes four patients with rare gliomas treated at the University Hospital, Ulm, between 2002 and 2024. Patients were selected based on unique histopathological features and long-term clinical follow-up. Clinical records, imaging, and histological data were reviewed. Molecular diagnostics followed WHO 2021 guidelines. Quality of life was assessed using standardized tools including the EQ-5D-5L, EQ VAS, the Distress Thermometer, and the Montreal Cognitive Assessment (MoCA). In the first case, a 51-year-old male’s diagnosis evolved from pleomorphic xanthoastrocytoma to a high-grade glioma with pleomorphic and pseudopapillary features, later identified as a neuroepithelial tumor with a PATZ1 fusion over 12 years. Despite multiple recurrences, extensive surgical interventions led to excellent outcomes. The second case involved a young female with long-term survival of astroblastoma, demonstrating significant improvements in both longevity and quality of life through personalized care. The third case involved a patient with oligodendroglioma, later transforming into glioblastoma, emphasizing the importance of continuous diagnostic reevaluation and adaptive treatment strategies, contributing to prolonged survival and quality of life improvements. Remarkably, the patient has achieved over 20 years of survival, including 10 years of being both therapy- and progression-free. The fourth case presents a young woman with neurofibromatosis type 1, initially misdiagnosed with glioblastoma based on histopathological findings. Subsequent molecular diagnostics revealed a subependymal giant cell astrocytoma-like astrocytoma, highlighting the critical role of early advanced diagnostic techniques. These cases underscore the importance of precise molecular diagnostics, individualized treatments, and ongoing diagnostic reevaluation to optimize outcomes. They also address the psychological impact of evolving diagnoses, stressing the need for comprehensive patient support. Even in complex cases, extensive surgical interventions can yield favorable results, reinforcing the value of adaptive, multidisciplinary strategies based on evolving tumor characteristics.
Open AccessNavigating Rarity: Pathological Challenges and Diagnostic Ambiguity in Rare Gliomas—A Case Series with a Focus on Personalized Treatment and Quality of Life
Gliomas are incurable, heterogeneous brain tumors, with rare forms often constituting diagnostic and treatment challenges. Molecular diagnostics, mainly implemented through the World Health Organization (WHO) 2021 guidelines, have refined the classification, but highlight difficulties in diagnosing rare gliomas remain. This case series analyzes four patients with rare gliomas treated at the University Hospital, Ulm, between 2002 and 2024. Patients were selected based on unique histopathological features and long-term clinical follow-up. Clinical records, imaging, and histological data were reviewed. Molecular diagnostics followed WHO 2021 guidelines. Quality of life was assessed using standardized tools including the EQ-5D-5L, EQ VAS, the Distress Thermometer, and the Montreal Cognitive Assessment (MoCA). In the first case, a 51-year-old male’s diagnosis evolved from pleomorphic xanthoastrocytoma to a high-grade glioma with pleomorphic and pseudopapillary features, later identified as a neuroepithelial tumor with a PATZ1 fusion over 12 years. Despite multiple recurrences, extensive surgical interventions led to excellent outcomes. The second case involved a young female with long-term survival of astroblastoma, demonstrating significant improvements in both longevity and quality of life through personalized care. The third case involved a patient with oligodendroglioma, later transforming into glioblastoma, emphasizing the importance of continuous diagnostic reevaluation and adaptive treatment strategies, contributing to prolonged survival and quality of life improvements. Remarkably, the patient has achieved over 20 years of survival, including 10 years of being both therapy- and progression-free. The fourth case presents a young woman with neurofibromatosis type 1, initially misdiagnosed with glioblastoma based on histopathological findings. Subsequent molecular diagnostics revealed a subependymal giant cell astrocytoma-like astrocytoma, highlighting the critical role of early advanced diagnostic techniques. These cases underscore the importance of precise molecular diagnostics, individualized treatments, and ongoing diagnostic reevaluation to optimize outcomes. They also address the psychological impact of evolving diagnoses, stressing the need for comprehensive patient support. Even in complex cases, extensive surgical interventions can yield favorable results, reinforcing the value of adaptive, multidisciplinary strategies based on evolving tumor characteristics.
- 1 December 2017
- Published by Elsevier in Clinical Neurophysiology
- Vol. 128 (12) , 2384-2391
Super-selective cervical nerve root stimulation in contralateral C7 transfer: An intraoperative study
- 1 December 2017
- Published by Elsevier in Clinical Neurophysiology
- Vol. 128 (12) , 2384-2391
Super-selective cervical nerve root stimulation in contralateral C7 transfer: An intraoperative study